000			05332cam a2200805Ia 4500
001			ocn745970855
003			OCoLC
005			20171116140158.0
006			m o d
007			cr |n|||||||||
008			101020s2011 njua ob 001 0 eng d
020			_a9781118023679 _q(electronic bk.)
020			_a1118023676 _q(electronic bk.)
020			_a9781118023655 _q(electronic bk.)
020			_a111802365X _q(electronic bk.)
020			_a9781118023662 _q(electronic bk.)
020			_a1118023668 _q(electronic bk.)
020			_z9780470616178 _q(Cloth)
020			_z0470616172 _q(Cloth)
020			_z1283175665
020			_z9781283175661
024	8		_a9786613175663
029	1		_aAU@ _b000049641635
029	1		_aDEBBG _bBV041911509
029	1		_aDEBSZ _b430989806
029	1		_aDEBSZ _b449240444
029	1		_aNZ1 _b14693210
029	1		_aSE4M6 _b120058359
029	1		_aDEBBG _bBV043393342
035			_a(OCoLC)745970855 _z(OCoLC)743204852 _z(OCoLC)746324257 _z(OCoLC)747412618 _z(OCoLC)747427281 _z(OCoLC)791305549 _z(OCoLC)811493653 _z(OCoLC)816850646
037			_a317566 _bMIL
040			_aCDX _beng _epn _cCDX _dIDEBK _dDG1 _dE7B _dYDXCP _dN$T _dOCLCQ _dMYG _dOCLCQ _dOCLCA _dOCLCF _dOCLCQ _dNLGGC _dOCLCQ _dDEBSZ _dMHW _dUKDOC _dDEBBG _dOCLCQ _dN$T _dOCLCQ
049			_aMAIN
050		4	_aHD9665.5 _b.D38 2011eb
060		4	_aQV 773
072		7	_aMED _x023000 _2bisacsh
072		7	_aMED _x058170 _2bisacsh
072		7	_aMED _x071000 _2bisacsh
072		7	_aMED _x072000 _2bisacsh
082	0	4	_a615.1068/4 _222
100	1		_aDavison, Mark, _d1968 March 1-
245	1	0	_aPharmaceutical anti-counterfeiting : combating the real danger from fake drugs / _cMark Davison. _h[electronic resource]
260			_aHoboken, N.J. : _bJohn Wiley & Sons, _c©2011.
300			_a1 online resource (xxiii, 402 pages) : _billustrations
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
504			_aIncludes bibliographical references and index.
505	0		_aFrontmatter -- General Themes. Introduction -- Origins and Context of Counterfeiting in Healthcare -- A Snapshot of the Problem -- Risks and Costs of Counterfeit Pharmaceuticals -- Anti-Counterfeiting Definitions -- Protecting and Educating Consumers -- Business Risks and Strategy -- Government Issues -- Intellectual Property and Anti-Counterfeiting -- Traceability or Authentication? -- Authentication. What is Authentication? -- Authentication of the Person -- Authentication of Bulk Products -- On-Dose and In-Dose Authentication -- Analytical Detection of Counterfeit Dosage Forms -- The Role of Packaging -- Printing Technologies -- Security Labels -- Holograms and DOVIDs -- Specialty Inks -- Covert Taggants and Forensic Markers -- General Conclusions on Printed Packaging and Security Labels -- Security of Primary Packaging -- Security of Secondary Packaging -- Analytical Methods for Packaging -- Security of Other Packaging Types -- Bulk Packaging and Transport Security -- Product Tracking. Rationale for Pharmaceutical Tracking -- Tracking Technologies -- Data Format, Generation, and Storage -- Management of Packaging Hierarchy -- Geographical Perspectives -- Product Tracking in Other Industries -- Supply Chain Security Processes -- Implementing Anti-Counterfeiting Initiatives-Practical Issues -- Conclusions and the Future. Where do we go from here? -- New Models, New Approaches -- Selected Examples from around the World -- Further Resources. A Patient's Guide to Avoiding Counterfeit Drugs -- Notes and References -- Glossary -- Further Resources. Information Sources -- Drug Regulators.
520			_aThis book overviews and integrates the business and technical issues that pharmaceutical companies need to know in order to combat the major global problem of counterfeit medicines. In addition to discussion of the problems, the author Davison addresses analytical techniques scientists use to detect counterfeits and presents some possible solutions to the threat of counterfeit medical products. Coverage moves from basic overview of the problem, costs / risks to consumers (toxic products, mistrust of drug companies) and business (revenue loss, public trust), government oversight and regulation, authentication strategies (packaging, analytical techniques), product tracking and supply chain, and case studies from around the globe.
588	0		_aPrint version record.
650		0	_aProduct counterfeiting.
650		0	_aDrug adulteration.
650		2	_aDrug Contamination.
650		2	_aConsumer Product Safety.
650		2	_aFraud _xprevention & control.
650		2	_aPharmaceutical Preparations _xstandards.
650		4	_aDrug adulteration.
650		4	_aProduct counterfeiting.
650		7	_aMEDICAL _xDrug Guides. _2bisacsh
650		7	_aMEDICAL _xNursing _xPharmacology. _2bisacsh
650		7	_aMEDICAL _xPharmacology. _2bisacsh
650		7	_aMEDICAL _xPharmacy. _2bisacsh
650		7	_aDrug adulteration. _2fast _0(OCoLC)fst00898652
650		7	_aProduct counterfeiting. _2fast _0(OCoLC)fst01078205
655		4	_aElectronic books.
776	0	8	_iPrint version: _z9786613175663 _w(DLC) 2010044590 _w(OCoLC)671465412
856	4	0	_uhttp://onlinelibrary.wiley.com/book/10.1002/9781118023679 _zWiley Online Library
942			_2ddc _cBK
999			_c205184 _d205184